Hsf1 was also shown to be an important factor for the emergence of an EMT phenotype in experimental tumor cells driven by the Neu oncogene or TGF-β treatment [63], as well as through control of the EMT regulator Slug downstream of HRG and HER2 [109]. The gene discussed is HSF1; the disease is neoplasm.